13 November 2024
Strong execution drives good growth in H1 7am, 13 November 2024 ─ Experian plc, the global data and technology company, today issues its financial report…
13 NOVEMBER 2024 FULLER, SMITH & TURNER P.L.C. (“Fuller’s”, the “Company”, or the “Group”) Financial results for the 26 weeks to 28 September 2024…
SSE plc CHIEF EXECUTIVE SUCCESSION 13 November 2024 Alistair Phillips-Davies, Chief Executive of SSE plc, has informed the Board that he intends to retire…
SSE PLC: interim resultsfor six months ended 30 September 2024 13 November 2024 DELIVERING MISSION CRITICAL INVESTMENT · Strong start to financial year, delivering adjusted…
12 November 2024
12 November 2024 AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of capital investment in…
12 November 2024 Koselugo showed statistically significant and clinically meaningful objective response rate vs. placebo in adults with neurofibromatosis type 1 in global KOMET Phase…
AstraZeneca 12 November 2024 9M and Q3 2024 results Upgrade to full year 2024 guidance underpinned by strong underlying growth momentum Revenue and EPS…
12 November 2024 Concurrent Technologies Plc (the “Company” or the “Group”) $3.72m Systems contract secured with leading defence provider in Asia Concurrent Technologies Plc…